Ricardo Zayas
Corporate Officer/Principal bij CATALENT, INC.
Vermogen: 347 243 $ op 30-04-2024
Profiel
Ricardo Zayas is currently the Senior VP-North America Biologic Operations at Catalent, Inc. He previously worked as the Vice President & General Manager-Operations at Wyeth Pharmaceuticals LLC from 2007 to 2009, Senior Vice President-Operations at AMAG Pharmaceuticals, Inc. from 2009 to 2011, and General Manager-Operations at Schering-Plough Pharmaceuticals from 2001 to 2007.
He also held positions as the Chief Operations Officer at Romark Global Pharma LLC and Chief Operating Officer & Operational Lead at OcyonBio.
Mr. Zayas received his undergraduate degree from Kansas State University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
CATALENT INC
0.00% | 01-08-2023 | 6 223 ( 0.00% ) | 347 243 $ | 30-04-2024 |
Actieve functies van Ricardo Zayas
| Bedrijven | Functie | Begin |
|---|---|---|
| CATALENT, INC. | Corporate Officer/Principal | 17-01-2023 |
Eerdere bekende functies van Ricardo Zayas
| Bedrijven | Functie | Einde |
|---|---|---|
| AMAG PHARMACEUTICALS, INC. | Operationeel Directeur | 11-02-2011 |
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Corporate Officer/Principal | 02-01-2009 |
| Schering-Plough Pharmaceuticals | Corporate Officer/Principal | 02-01-2007 |
| Ocyonbio | Operationeel Directeur | - |
Romark Global Pharma LLC
 Romark Global Pharma LLC Pharmaceuticals: MajorHealth Technology Romark Global Pharma LLC engages in the operation of an integrated biopharmaceutical company. The firm specializes in the discovery, development, and commercialization of small molecules for treating infectious diseases and cancers. The company was founded on November 14, 2014 and is headquartered in San Juan, Puerto Rico. | Operationeel Directeur | - |
Opleiding van Ricardo Zayas
| Kansas State University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CATALENT, INC. | Health Technology |
| Bedrijven in privébezit | 5 |
|---|---|
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
Wyeth Pharmaceuticals LLC
Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Health Technology |
| Schering-Plough Pharmaceuticals | |
Romark Global Pharma LLC
Romark Global Pharma LLC Pharmaceuticals: MajorHealth Technology Romark Global Pharma LLC engages in the operation of an integrated biopharmaceutical company. The firm specializes in the discovery, development, and commercialization of small molecules for treating infectious diseases and cancers. The company was founded on November 14, 2014 and is headquartered in San Juan, Puerto Rico. | Health Technology |
| Ocyonbio |